Arcellx Announces Participation at the Morgan Stanley 20th Annual Global Healthcare Conference

/PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for...

Related Keywords

Andrea Cohen ,Myesha Lacy ,Exchange Commission ,Arcellx Inc ,Morgan Stanley ,Drug Administration ,Securities Exchange ,Nasdaq ,Sam Brown Inc ,Annual Global Healthcare Conference ,Fast Track ,Orphan Drug ,Regenerative Medicine Advanced Therapy ,Securities Act ,Securities Exchange Act ,Risk Factors ,Annual Report ,Quarterly Reports ,Current Reports ,Arcellx ,Nc ,